Caplight Directory>Investors>LifeSci Venture Partners>Lifesciventure


LifeSci Venture Partners

LifeSci Venture Partners

—linkedin.com

Overview

LifeSci Venture Partners is the early stage investing arm of LifeSci Partners, a unique life sciences and healthcare consultancy formed in 2010. The firm focuses on pre-public institutional rounds of transformational healthcare companies managed by exceptional founder/entrepreneurs . LifeSci Venture Partners seeks out the most promising young companies and talented founders to partner with and nurture to help create tomorrow's cures . The firm principally invests in companies which have achieved proof of concept and plan to transition to the public markets within 24 months .

Year Founded

2017

Portfolio Companies

20

Investments

CompanyDateStageLead
Veradermics Inc.Oct 2025Series CCo-investor
BiolinqApr 2025Series CCo-investor
Candid TherapeuticsSep 2024Series ACo-investor
Averto MedicalMay 2024Series ACo-investor
Profound BioFeb 2024Series BCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

Headquarters—
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.